Bibliometric Analysis of International Scientific Production on Pharmacologic Treatments for SARS-CoV-2/COVID-19 During 2020
Metadatos
Afficher la notice complèteAuteur
Ruiz Fresneda, Miguel Ángel; Jiménez Contreras, Evaristo; Ruiz Fresneda, Carlos; Ruiz Pérez, RafaelEditorial
Frontiers
Materia
COVID-19 SARS-CoV-2 Scientific production Bibliometric analysis Pharmacologic treatments Bibliometric network Visualization
Date
2022-01-20Referencia bibliográfica
Ruiz-Fresneda MA... [et al.] (2022) Bibliometric Analysis of International Scientific Production on Pharmacologic Treatments for SARS-CoV-2/COVID-19 During 2020. Front. Public Health 9:778203. doi: [10.3389/fpubh.2021.778203]
Patrocinador
Junta de Andalucía. Spain. HUM.777-EC3 Research GroupRésumé
Background: COVID-19 is causing a grave global health and economic crisis and the
fight against the pandemic has led to unprecedented scientific activity. Bibliometrics
could be a useful tool for guiding future researches lines and promoting international
collaboration for an effective treatment. For this purpose, we have conducted a
bibliometric analysis of scientific publications on drugs and therapies used to treat
COVID-19 during 2020.
Methods: Data source: Web of Science. We gathered data on scientific production
relating to drugs used to treat COVID-19. We calculated impact factors and
analyzed production by institution, country, and journal, visualizing our results in
bibliometric networks.
Results: In 1 year, production relating to COVID-19 exceeded 100 000 publications, with
over 6,500 on Drugs and COVID-19. Research into hydroxychloroquine and chloroquine,
remdesivir, lopinavir and ritonavir, tocilizumab and convalescent plasma is particularly
noteworthy. Mean citations/study range from 11.9 to 15.4. Producer institutions fall
into three groups: one in the US and centered on Harvard Medical School; another in
Europe led by INSERS; and another in China led by Huazhong University of Science and
Technology. Production by journal is widespread but the Journal of Medical Virology,
International Journal of Antimicrobial Agents, and American Journal of Transplantation
are noteworthy.
Conclusions: The volume of research that is currently under way is comparable to
the magnitude of the pandemic itself. Such a high volume of studies is infrequent and
the impact they have achieved has no known precedent. The producing countries are
those with highest incidence of the pandemic and greatest scientific potential; moreover,
inter-agency and international collaboration has reached extraordinarily high levels.